{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:55:14Z","timestamp":1790434514863,"version":"4.1.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014807","name":"Nagoya University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16lk0103017h0003"],"award-info":[{"award-number":["16lk0103017h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229639","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T17:26:10Z","timestamp":1586798770000},"page":"e0229639","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-1586","authenticated-orcid":true,"given":"Hiroshi","family":"Kitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachiyo","family":"Kuwatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"pone.0229639.ref001","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 causes the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"R Shiang","year":"1994","journal-title":"Cell"},{"issue":"15","key":"pone.0229639.ref002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"F Rousseau","year":"1994","journal-title":"Nature"},{"issue":"4","key":"pone.0229639.ref003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00223-019-00518-z","article-title":"Physical, mental, and social problems of adolescent and adult patients with achondroplasia","volume":"104","author":"M Matsushita","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"pone.0229639.ref004","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00431-017-2923-y","article-title":"Final adult height in long-term growth hormone-treated achondroplasia patients","volume":"176","author":"D Harada","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"9","key":"pone.0229639.ref005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1302\/0301-620X.96B9.33840","article-title":"Early and late fracture following extensive limb lengthening in patients with achondroplasia and hypochondroplasia","volume":"96-B","author":"H Kitoh","year":"2014","journal-title":"Bone Joint J"},{"issue":"1","key":"pone.0229639.ref006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"A Yasoda","year":"2004","journal-title":"Nat Med"},{"issue":"5","key":"pone.0229639.ref007","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI83926","article-title":"Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model","volume":"126","author":"D Komla-Ebri","year":"2016","journal-title":"J Clin Invest"},{"issue":"11","key":"pone.0229639.ref008","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/mt.2016.158","article-title":"Dual therapeutic action of a neutralizing anti-FGF2 aptamer in bone disease and bone cancer","volume":"24","author":"L Jin","year":"2016","journal-title":"Mol Ther"},{"issue":"203","key":"pone.0229639.ref009","doi-asserted-by":"crossref","first-page":"203ra124","DOI":"10.1126\/scitranslmed.3006247","article-title":"Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice","volume":"5","author":"S Garcia","year":"2013","journal-title":"Sci Transl Med"},{"issue":"7519","key":"pone.0229639.ref010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"A Yamashita","year":"2014","journal-title":"Nature"},{"key":"pone.0229639.ref011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMoa1813446","article-title":"C-type natriuretic peptide analog therapy in children with achondroplasia","volume":"381","author":"R Savarirayan","year":"2019","journal-title":"New Engl J Med"},{"issue":"12","key":"pone.0229639.ref012","doi-asserted-by":"crossref","first-page":"e81569","DOI":"10.1371\/journal.pone.0081569","article-title":"Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormaly activated FGFR3 signaling in achondroplasia","volume":"8","author":"M Matsushita","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"pone.0229639.ref013","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2014-1914","article-title":"Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene","volume":"156","author":"M Matsushita","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0229639.ref014","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1038\/s41598-017-07044-8","article-title":"Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia","volume":"7","author":"M Matsushita","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0229639.ref015","volume-title":"Pharmacokinetic & Pharmacodynamic Data Analysis: Concepts and Applications","author":"J Gabrielsson","year":"2006"},{"issue":"9","key":"pone.0229639.ref016","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0091270011414575","article-title":"Meclizine metabolism and pharmacokinetics: formulation on its absorption","volume":"52","author":"Z Wang","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"pone.0229639.ref017","doi-asserted-by":"crossref","first-page":"e00418","DOI":"10.1002\/prp2.418","article-title":"Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 study","volume":"6","author":"K Brown","year":"2018","journal-title":"Pharmacol Res Perspect"},{"issue":"9582","key":"pone.0229639.ref018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"WA Horton","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"pone.0229639.ref019","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/sj.ijo.0803402","article-title":"Body composition in normal weight, overweight and obese children: matched case-control analyses of total and regional tissue masses, and body composition trends in relation to relative weight","volume":"30","author":"JC Wells","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"pone.0229639.ref020","first-page":"111","article-title":"A review of body water status and the effects of age and body fatness in children and adults","volume":"11","author":"WC Chumlea","year":"2007","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"pone.0229639.ref021","first-page":"e121","article-title":"Childhood obesity: Pharmacokinetic considerations for drug used in the intensive care unit","volume":"117","author":"FA Donoso","year":"2019","journal-title":"Arch Argent Pediatr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T05:01:08Z","timestamp":1590210068000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229639"}},"subtitle":[],"editor":[{"given":"Karel","family":"Allegaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229639","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]}}}